Oxford Financial Group’s Lineage Cell Therapeutics LCTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.5K | Hold |
12,630
| – | – | ﹤0.01% | 252 |
|
|
2025
Q1 | $5.7K | Hold |
12,630
| – | – | ﹤0.01% | 256 |
|
|
2024
Q4 | $6.35K | Hold |
12,630
| – | – | ﹤0.01% | 291 |
|
|
2024
Q3 | $11.4K | Hold |
12,630
| – | – | ﹤0.01% | 279 |
|
|
2024
Q2 | $12.6K | Hold |
12,630
| – | – | ﹤0.01% | 303 |
|
|
2024
Q1 | $18.7K | Hold |
12,630
| – | – | ﹤0.01% | 262 |
|
|
2023
Q4 | $13.8K | Hold |
12,630
| – | – | ﹤0.01% | 280 |
|
|
2023
Q3 | $14.9K | Hold |
12,630
| – | – | ﹤0.01% | 253 |
|
|
2023
Q2 | $17.8K | Hold |
12,630
| – | – | ﹤0.01% | 276 |
|
|
2023
Q1 | $18.9K | Hold |
12,630
| – | – | ﹤0.01% | 237 |
|
|
2022
Q4 | $14.8K | Hold |
12,630
| – | – | ﹤0.01% | 242 |
|
|
2022
Q3 | $14K | Hold |
12,630
| – | – | ﹤0.01% | 220 |
|
|
2022
Q2 | $20K | Hold |
12,630
| – | – | ﹤0.01% | 241 |
|
|
2022
Q1 | $19K | Hold |
12,630
| – | – | ﹤0.01% | 238 |
|
|
2021
Q4 | $31K | Hold |
12,630
| – | – | ﹤0.01% | 241 |
|
|
2021
Q3 | $32K | Hold |
12,630
| – | – | ﹤0.01% | 220 |
|
|
2021
Q2 | $36K | Hold |
12,630
| – | – | ﹤0.01% | 199 |
|
|
2021
Q1 | $30K | Hold |
12,630
| – | – | ﹤0.01% | 194 |
|
|
2020
Q4 | $22K | Buy |
+12,630
| New | +$22K | ﹤0.01% | 193 |
|